Kronos Bio Inc (KRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2000 | 09-1999 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 23,201 | N/A |
| Marketable Securities | 10,788 | N/A |
| Receivables | 71,493 | N/A |
| Income taxes - deferred | 5,916 | N/A |
| Other current assets | 13,750 | 0 |
| TOTAL | $125,148 | $N/A |
| Non-Current Assets | ||
| PPE Net | 37,082 | N/A |
| Investments And Advances | 17,450 | 0 |
| Intangibles | 29,421 | 0 |
| Other Non-Current Assets | 30,388 | 0 |
| TOTAL | $114,341 | $N/A |
| Total Assets | $239,489 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 8,278 | 0 |
| Accrued Expenses | 34,218 | N/A |
| TOTAL | $114,430 | $N/A |
| Non-Current Liabilities | ||
| Deferred Revenues | 71,934 | N/A |
| Other Non-Current Liabilities | 1,455 | 0 |
| TOTAL | $17,269 | $N/A |
| Total Liabilities | $131,699 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 190 | N/A |
| Retained earnings | 97,844 | N/A |
| Other shareholders' equity | -1,022 | 0 |
| TOTAL | $107,790 | $N/A |
| Total Liabilities And Equity | $239,489 | $0 |